文献速递传染病防控与疫情报告免疫规划

利用家蚕蛹高产生产诺如病毒GII.4病毒样颗粒及其保护性免疫原性评价

High yield production of norovirus GII.4 virus-like particles using silkworm pupae and evaluation of their protective immunogenicity.
PubMed 文献 · Vaccine · 2022-12-15

研究构建表达诺如病毒GII.4 VP1蛋白的重组杆状病毒,比较家蚕蛹与幼虫脂肪体的表达效率,从5只蚕蛹纯化获得约4.9 mg VP1蛋白并确认其形成直径约40 nm的病毒样颗粒。小鼠抗血清可阻断病毒样颗粒与猪胃黏蛋白组织血型抗原结合,并阻断人诱导多能干细胞来源肠上皮细胞中的诺如病毒感染。

要点

  • 家蚕蛹表达诺如病毒GII.4 VP1蛋白的效率高于幼虫脂肪体。
  • 仅5只蚕蛹即纯化获得约4.9 mg VP1蛋白,并形成直径约40 nm病毒样颗粒。
  • 小鼠抗血清可阻断病毒样颗粒与组织血型抗原结合及肠上皮细胞感染。

核心结论

  • 利用家蚕表达载体系统可从少量蚕蛹中以毫克级获得能诱导保护性抗体的诺如病毒病毒样颗粒。

研究设计与样本

  • 研究构建表达诺如病毒GII.4 VP1蛋白的重组杆状病毒,比较家蚕蛹与幼虫脂肪体的表达效率,并纯化蛋白进行颗粒鉴定和小鼠免疫评价。

主要发现

  • 感染杆状病毒的家蚕蛹表达诺如病毒VP1蛋白的效率高于家蚕幼虫脂肪体。
  • 仅从5只家蚕蛹中纯化获得约4.9 mg诺如病毒VP1蛋白。
  • 纯化的VP1蛋白经动态光散射和电子显微镜确认形成直径约40 nm的病毒样颗粒。
  • 免疫小鼠的抗血清可阻断诺如病毒病毒样颗粒与猪胃黏蛋白组织血型抗原结合,并阻断人诱导多能干细胞来源肠上皮细胞中的诺如病毒感染。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Noroviruses (NoVs) are one of the major causes of acute viral gastroenteritis in humans. Virus-like particles (VLPs) without genomes that mimic the capsid structure of viruses are promising vaccine candidates for the prevention of NoVs infection. To produce large amounts of recombinant protein, including VLPs, the silkworm-expression vector system (silkworm-BEVS) is an efficient and powerful tool. In this study, we constructed a recombinant baculovirus that expresses VP1 protein, the major structural protein of NoV GII.4. Expression analysis showed that the baculovirus-infected silkworm pupae expressed NoV VP1 protein more efficiently than silkworm larval fat bodies. We obtained about 4.9 mg of purified NoV VP1 protein from only five silkworm pupae. The purified VP1 protein was confirmed by dynamic light scattering and electron microscopy to form VLPs of approximately 40 nm in diameter. Antisera from mice immunized with the antigen blocked NoV VLPs binding to histo-blood group antigens of pig gastric mucin and also blocked NoV infection in intestinal epithelial cells derived from human induced pluripotent stem (iPS) cells. Our findings demonstrated that NoV VLP eliciting protective antibodies could be obtained in milligram quantities from a few silkworm pupae using the silkworm-BEVS.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Masuda A, Man Lee J, Miyata T, et al. High yield production of norovirus GII.4 virus-like particles using silkworm pupae and evaluation of their protective immunogenicity. Vaccine. 2022. PMID: 36528444. doi:10.1016/j.vaccine.2022.12.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。